Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Where are the U.S. pharma and biotech jobs in mid-2024?

By Brian Buntz | May 31, 2024

Many of the job cuts in 2024 are in Massachusetts, but the state still has one of the densest concentrations of job listings based on a dataset of more than 3,300 online job postings from May. Yet the Northeast Megalopolis excluding the Bay State was home to more jobs overall, with states such as New Jersey, New York and Pennsylvania jointly accounting for more than 60% more listings than Massachusetts.

Other notable hubs for job listings include Southern Illinois, the San Francisco Bay Area, Southern California and the Research Triangle in North Carolina. Smaller pockets of biopharma jobs appear in cities such as Seattle, Indianapolis, St. Louis, Kansas City, Tampa and Baton Rouge.

Drug Discovery & Development has churned out a variety of maps recently highlighting the biopharma sector, including one showing layoff hotspots and a global breakdown of VC funding, layoffs and new plant announcements that includes some hiring data as well. For a breakdown of top-paying job title types across pharma, check out “Pharma and biotech salary review: Who’s earning the most in 2024?”

Senior roles occur frequently in job postings

The most common job posting in the dataset was research associate followed by validation engineer and microbiologist titles. As of mid-May, research associate listings were more likely to be in hubs such as Boston, San Francisco and San Diego, while validation engineers were more common in pharma manufacturing hubs such as New Jersey and North Carolina. Some roles, such as Research Assistants and Scientists, were more common in academic research settings and specialized research centers or universities.

Word cloud based on more than 3,300 job titles

Among the thousands of listings, a significant number were for senior roles as the bar chart below shows. “Manager” and “senior” were each mentioned more than 500 times in job titles. “Director” was mentioned 399 times. The image below shows the Term Frequency-Inverse Document Frequency (TF-IDF) score for the top terms. TF-IDF is a statistical measure that gauges how relevant a word is to a document. TF-IDF and simple word counts measure different things. TF-IDF considers the term’s importance relative to the entire dataset, while word counts simply counts occurrences.

Most frequent roles in biopharma job titles

Breakdown of best-paid open pharma positions

While many job postings did not include salary information, the ones that did reinforced the fact that the top-paying jobs tend to be concentrated in the San Francisco Bay Area, Boston/Cambridge, New York City/New Jersey and San Diego. California was home to the top-paying maximum salaries with especially high-paying open positions including vice president of intellectual property at a gene therapy company and lead the HIV drug development team at a global pharmaceutical giant. Several of the salaries in the Bay Area exceeded $300,000.

In San Diego, high demand for expertise in areas like toxicology and immunology is reflected in the salaries offered for roles like senior director of toxicology, reaching up to $260,000. Bioinformatics, a field experiencing swift growth, also commands top dollar, with positions like bioinformatics scientist II offering salaries up to $190,000.

Most common bigrams in job titles

The most commonly occurring pairs of words in job titles.

In Boston/Cambridge, there were a number of high-paying open positions in medical affairs, research and clinical development. Senior medical director roles focused on critical areas like pharmacovigilance and drug safety command salaries surpassing $300,000. Additionally, leadership positions within global pharmaceutical companies have salaries in the same range.

Other examples of high-paying positions across the country include a New Jersey–based associate vice president/therapeutic area head focusing on cardiovascular & respiratory with a max salary of more than $500,000. Regional business director roles at Big Pharma firms also pay well with salaries sometimes exceeding $250,000.

The map below filters for select open positions related to either pharma or biotech with a max salary of at least $100,000 annually.

A note on the methodology and data source: While the listings in the dataset provide a snapshot, the data is by no means exhaustive. Consider that a single biopharma giant could have hundreds of job postings. Data was retrieved using queries for “pharma” and “biotech” and for searching for open positions at prominent Big Pharma companies across the U.S. The resulting dataset included a handful of OUS locations as well, but the vast majority were domestic. Location data (city names) were converted into coordinates using the Google Maps API. Data manipulation was based on open-source Python tools. The underlying data is not exhaustive and does not cover all possible job postings. While a dataset of more than 3,300 entries is substantial, a single Big Pharma may have hundreds of job postings at any given time.


Filed Under: Drug Discovery and Development
Tagged With: biotech jobs, highest paying biotech hubs, job market trends, pharma jobs, remote pharma jobs, research associate positions, top pharma locations, validation engineer roles
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].

Related Articles Read More >

Sai Life Sciences to double process R&D capacity with new Hyderabad facility
How stereo-correct data can de-risk AI-driven drug discovery
Pfizer stock jumps 14% as TrumpRx drug pricing deal eases tariff fears
See it in 1 second, act in 60: Eschbach’s take on how visual factories enable measurable decisions
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE